FROM CONCEPT TO PRODUCT
Start your journey today
We're experienced in commercialising new medical devices with clinical creators working in the NHS and beyond - call us today for a confidential, no obligation conversation
Medovate Gold Sponsors of the 4th ESRA e-Congress
26th Feb 2021
Medovate are pleased to be a Gold Sponsor of this year’s ESRA (European Society of Regional Anaesthesia & Pain Therapy) e-Congress taking place on Saturday 13th March 2021.
The fully virtual e-congress will feature the most up-to-date information on regional anaesthesia and pain management from over 50 key industry opinion leaders.
The interactive congress and e-symposia also includes an extended programme of 15 hours broadcasted live all over the world from 7:00 AM to 10:15 PM (GMT +1 Paris time).
Throughout the day participants will be able to visit the virtual Medovate e-booth and take part in a live chat with the Medovate team to discover more about our pioneering SAFIRA® (SAFer Injection for Regional Anaesthesia) device for regional anaesthesia. There will be a selection of marketing materials to download, as well as access to related videos.
Medovate will also be sponsoring an Industry Symposium as part of the programme ‘Mitigating for Nerve Injury by Innovation: Introducing SAFIRA’ taking place at 13:15 hours from Studio 2.
Speakers include:
- Dr Benjamin Fox, Consultant Anaesthetist, the Queen Elizabeth Hospital King’s Lynn NHS Foundation Trust (also Chair & Moderator)
- Dr Robin Heij, Consultant in Critical Care, the Queen Elizabeth Hospital King’s Lynn NHS Foundation Trust
- Dr Peter Young, Consultant in Critical Care, the Queen Elizabeth Hospital King’s Lynn NHS Foundation Trust
- Dr Maria Paz Sebastian, Consultant Anaesthetist, the Royal National Orthopaedic Hospital NHS Trust
Developed in collaboration with UK National Health Service (NHS) clinicians, SAFIRA® transforms the technique of Peripheral Nerve Blockade into a one-person procedure, giving the anaesthetist full control of the injection at all times.
The pioneering technology also improves patient safety by helping reduce the risk of nerve damage, as it prevents anaesthetic from being injected at high pressures. Furthermore, economic modelling has shown SAFIRA® has the potential to help generate significant time and cost savings in a medical setting.
The ESRA e-Congress is a great opportunity to find out more about the latest developments in anaesthesia and learn more about our ground-breaking technology which has been designed to help make regional anaesthesia safer for patients worldwide. It is free to attend for ESRA members / 70 Euro for non-members.
CLICK HERE to go to the ESRA e-Congress website to find out more or sign up to attend